Skip to main content

Table 3 Correlation between circulating EOS and the T cell immunity in the severe patients

From: Circulating eosinophils associated with responsiveness to COVID-19 vaccine and the disease severity in patients with SARS-CoV-2 omicron variant infection

Severe patients

Low EOS

(< 0.02 × 10^9/L) (n = 101)

Normal EOS (≥ 0.02 × 10^9/L) (n = 65)

P value

Sex

  

0.307

 Male

61(60.40%)

34 (52.31%)

 

 Female

40 (39.60%)

31(47.69%)

 

Age

78(78.00,92.50)

81(74.00,90.00)

0.195

WBC (10^9/L)

7.05(5.32,10.18)

6.64(4.26,8.88)

0.102

EOS (10^9/L)

0(0.00,0.00)

0.04(0.02,0.08)

< 0.001

Neutrophils (10^9/L)

5.44(3.95, 8.54)

4.48(2.40,7.12)

0.026

Lymphocytes (10^9/L)

0.7(0.46,1.03)

0.99(0.70,1.50)

0.006

Monocytes (10^9/L)

0.465(0.31,0.77)

0.5(0.38,0.71)

0.825

CRP(mg/L)

41.96(10.89,96.27)

24.72(3.97,63.33)

0.001

D-Dimer(ug/ml)

1.42(0.96,3.55)

1.41(0.79,2.74)

0.365

CD4 (cell/ul)

272.23(138.23,407.49)

353.49(220.85,487.25)

0.011

CD8 (cell/ul)

140(81.02,291.47)

219.75(103.57,368.08)

0.058

CD4/CD8

1.7(0.9,2.59)

1.31(1.01,2.02)

0.229

NLR

7.79(3.92, 15.45)

3.85(2.34, 8.01)

0.026

  1. Data are presented as median (IQR) or n (%). p values comparing the group of mild and severe patients are from χ² test or Mann-Whitney U test. EOS, Eosinophils. NLR, Neutrophil-to-Lymphocyte Ratio